IC
PMN icon

Ikarian Capital’s ProMIS Neurosciences PMN Stock Holding History

Ikarian Capital’s Portfolio PMN Stock Details PMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.7M Buy
205,000
+150,000
+273% +$1.63M 0.29% 77
2026
Q1 		$699K Buy
+55,000
New +$820K 0.06% 119

Other funds holding PMN

JT
Jupiter Topco New York $245B AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ABG
Ally Bridge Group New York $113M AUM 245.92% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Ikarian Capital's PMN Position: Q2 2026 in Review

Ikarian Capital increased its ProMIS Neurosciences (PMN) stake by 273% in Q2 2026, buying an estimated $1.63M and bringing the position to 205,000 shares worth $2.7M. The position accounts for 0.29% of the portfolio, ranked #77.

Ikarian Capital first reported a position in PMN in Q1 2026 and has held it in 2 quarters since. 27 funds tracked by Wall St. Rank hold PMN as of Q2 2026.

  • Ikarian Capital held 205,000 shares of ProMIS Neurosciences worth $2.7M as of Q2 2026.
  • Ikarian Capital bought 150,000 ProMIS Neurosciences shares in Q2 2026, an estimated $1.63M.
  • ProMIS Neurosciences made up 0.29% of Ikarian Capital's portfolio in Q2 2026, its #77 holding.
  • Ikarian Capital first reported a position in ProMIS Neurosciences in Q1 2026 and has held it in 2 quarters since.
  • 27 funds tracked by Wall St. Rank held ProMIS Neurosciences as of Q2 2026.

Based on Ikarian Capital's 13F filing for Q2 2026, filed 14 Aug 2026.